217 related articles for article (PubMed ID: 22732306)
1. Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice.
Zhang X; Bai Q; Kakiyama G; Xu L; Kim JK; Pandak WM; Ren S
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):262-70. PubMed ID: 22732306
[TBL] [Abstract][Full Text] [Related]
2. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells.
Bai Q; Xu L; Kakiyama G; Runge-Morris MA; Hylemon PB; Yin L; Pandak WM; Ren S
Atherosclerosis; 2011 Feb; 214(2):350-6. PubMed ID: 21146170
[TBL] [Abstract][Full Text] [Related]
3. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease.
Bai Q; Zhang X; Xu L; Kakiyama G; Heuman D; Sanyal A; Pandak WM; Yin L; Xie W; Ren S
Metabolism; 2012 Jun; 61(6):836-45. PubMed ID: 22225954
[TBL] [Abstract][Full Text] [Related]
4. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
[TBL] [Abstract][Full Text] [Related]
5. Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation.
Ren S; Ning Y
Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E123-30. PubMed ID: 24302009
[TBL] [Abstract][Full Text] [Related]
6. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of the regulatory oxysterol, 5-cholesten-3beta,25-diol 3-sulfate, in hepatocytes.
Li X; Pandak WM; Erickson SK; Ma Y; Yin L; Hylemon P; Ren S
J Lipid Res; 2007 Dec; 48(12):2587-96. PubMed ID: 17890683
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro.
Zhang X; Bai Q; Xu L; Kakiyama G; Pandak WM; Zhang Z; Ren S
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G344-55. PubMed ID: 22679001
[TBL] [Abstract][Full Text] [Related]
9. Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate.
Xu L; Bai Q; Rodriguez-Agudo D; Hylemon PB; Heuman DM; Pandak WM; Ren S
Lipids; 2010 Sep; 45(9):821-32. PubMed ID: 20700770
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury.
Wang Z; Yang X; Chen L; Zhi X; Lu H; Ning Y; Yeong J; Chen S; Yin L; Wang X; Li X
Arch Toxicol; 2017 Jan; 91(1):271-287. PubMed ID: 27052460
[TBL] [Abstract][Full Text] [Related]
11. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
[TBL] [Abstract][Full Text] [Related]
12. Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes.
Ren S; Li X; Rodriguez-Agudo D; Gil G; Hylemon P; Pandak WM
Biochem Biophys Res Commun; 2007 Sep; 360(4):802-8. PubMed ID: 17624300
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
14. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol metabolites alleviate injured liver function and decrease mortality in an LPS-induced mouse model.
Ning Y; Kim JK; Min HK; Ren S
Metabolism; 2017 Jun; 71():83-93. PubMed ID: 28521882
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice.
Chen W; Chen G; Head DL; Mangelsdorf DJ; Russell DW
Cell Metab; 2007 Jan; 5(1):73-9. PubMed ID: 17189208
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.
Zhang X; Xu Y; Bai Q; Li X; Han J; Hou Y; Ji Y; Zhang Z
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G87-G96. PubMed ID: 32475129
[TBL] [Abstract][Full Text] [Related]
18. 25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARγ signaling in human THP-1 macrophages.
Xu L; Shen S; Ma Y; Kim JK; Rodriguez-Agudo D; Heuman DM; Hylemon PB; Pandak WM; Ren S
Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E788-99. PubMed ID: 22275753
[TBL] [Abstract][Full Text] [Related]
19. The influence of ligand-activated LXR on primary human trophoblasts.
Larkin JC; Sears SB; Sadovsky Y
Placenta; 2014 Nov; 35(11):919-24. PubMed ID: 25255963
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
